MRI radiomics for the prediction of recurrence in patients with clinically non-functioning pituitary macroadenomas

被引:33
|
作者
Machado, Leonardo F. [1 ]
Elias, Paula C. L. [3 ]
Moreira, Ayrton C. [3 ]
dos Santos, Antonio C. [4 ]
Murta Junior, Luiz O. [1 ,2 ]
机构
[1] Univ Sao Paulo, Dept Phys, Fac Philosophy Sci & Letters Ribeirao Preto, Ribeirao Preto, SP, Brazil
[2] Univ Sao Paulo, Dept Comp & Math, Fac Philosophy Sci & Letters Ribeirao Preto, Ribeirao Preto, SP, Brazil
[3] Univ Sao Paulo, Clin Hosp, Fac Med Ribeirao Preto, Endocrinol Div, Ribeirao Preto, SP, Brazil
[4] Univ Sao Paulo, Clin Hosp, Fac Med Ribeirao Preto, Endocrinol Div,Ctr Image Sci & Med Phys, Ribeirao Preto, SP, Brazil
关键词
Radiomics; MRI; Pituitary adenoma; Tumor recurrence; Machine learning; TEXTURE ANALYSIS; ADENOMAS; CLASSIFICATION; RADIOTHERAPY; MANAGEMENT; FEATURES; TUMORS; DIAGNOSIS; PATTERN; KI-67;
D O I
10.1016/j.compbiomed.2020.103966
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Twelve to 66% of patients with clinically non-functioning pituitary adenoma (NFPA) experience tumor recurrence 1-5 years after the first surgery. Nevertheless, there is still no recurrence prediction factor concisely established and reproduced in the literature for NFPA management. The present study evaluates the prognostic value of MRI Radiomics features combined with machine learning models to assess recurrence after the first surgery in patients with clinically non-functioning pituitary adenomas (NFPA). We carried out a retrospective study on 27 patients with NFPA, 10 patients having experienced tumor recurrence after the first surgery and 17 who did not. Preoperative 3D T-1 contrast-enhanced MR images of patients were used to extract up to 255 Radiomics features from two and three-dimensional segmented regions. Additionally, gender, age at first surgery, and the presence of remnant tumor tissue were investigated to find the correlation with NFPA recurrence. Conventional statistics tests were used to evaluate whether the outcome patient groups (stable and recurrent) were different considering each feature individually. Additionally, five well-known machine-learning algorithms were used in combination with Radiomic features to classify recurrent and stable lesions. We found statistical evidence (p < 0.02) for 6 two-dimensional and 13 three-dimensional radiomic features. We achieved accuracies of up to 96.3% for 3D-feature based models and up to 92.6% accuracies for 2D-feature based models. 3D-feature based models achieved better performances using considerably fewer features when compared to 2D-feature based models. We concluded that Radiomics have the potential of NFPA recurrence prediction after the first surgery. Three-dimensional Radiomics have superior discrimination power to predict NFPA recurrence than two-dimensional radiomic features. Finally, the combination of Radiomics with machine-learning algorithms can offer computational models capable of non-invasive, unbiased, and quick assessment that might improve the prediction of NFPA recurrence.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Is systematic Gadolinium injection relevant during MRI follow-up for non-functioning pituitary macroadenomas?
    Villemaire, Axel
    Adam, Gilles
    Fayolle, Helio
    Roques, Margaux
    Darcourt, Jean
    Caron, Philippe
    Bonneville, Fabrice
    JOURNAL OF NEURORADIOLOGY, 2023, 50 (01) : 3 - 8
  • [22] Telomerase expression in clinically non-functioning pituitary adenomas
    Ogino, Liana Lumi
    Lamback, Elisa Baranski
    Guterres, Alexandro
    de Azeredo Lima, Carlos Henrique
    Henriques, Daniel Gomes
    Barbosa, Monique Alvares
    Silva, Debora Aparecida
    da Silva Camacho, Aline Helen
    Chimelli, Leila
    Kasuki, Leandro
    Gadelha, Monica R.
    ENDOCRINE, 2021, 72 (01) : 208 - 215
  • [23] Telomerase expression in clinically non-functioning pituitary adenomas
    Liana Lumi Ogino
    Elisa Baranski Lamback
    Alexandro Guterres
    Carlos Henrique de Azeredo Lima
    Daniel Gomes Henriques
    Monique Alvares Barbosa
    Débora Aparecida Silva
    Aline Helen da Silva Camacho
    Leila Chimelli
    Leandro Kasuki
    Mônica R. Gadelha
    Endocrine, 2021, 72 : 208 - 215
  • [24] Biochemical markers for clinically non-functioning pituitary tumours
    Harris, PE
    CLINICAL ENDOCRINOLOGY, 1998, 49 (02) : 163 - 164
  • [25] Medical therapy for clinically non-functioning pituitary adenomas
    Colao, Annamaria
    Di Somma, Carolina
    Pivonello, Rosario
    Faggiano, Antongiulio
    Lombardi, Gaetano
    Savastano, Silvia
    ENDOCRINE-RELATED CANCER, 2008, 15 (04) : 905 - 915
  • [26] Cabergoline treatment for surgery-naïve non-functioning pituitary macroadenomas
    Ayalon-Dangur, Irit
    Turjeman, Adi
    Hirsch, Dania
    Robenshtok, Eyal
    Tsvetov, Gloria
    Gorshtein, Alexander
    Masri, Hiba
    Shraga-Slutzky, Ilana
    Manisterski, Yossi
    Akirov, Amit
    Shimon, Ilan
    PITUITARY, 2024, 27 (01) : 52 - 60
  • [27] Deferred Radiotherapy After Debulking of Non-functioning Pituitary Macroadenomas: Clinical Outcomes
    Nicholas, Sarah E.
    Salvatori, Roberto
    Quinones-Hinojosa, Alfredo
    Redmond, Kristin
    Gallia, Gary
    Lim, Michael
    Rigamonti, Daniele
    Brem, Henry
    Kleinberg, Lawrence
    FRONTIERS IN ONCOLOGY, 2019, 8
  • [28] Predictors of hormonal dysfunction in the postoperative of non-functioning pituitary macroadenomas: a systematic review
    Rossetti Junior, A.
    Salles, I. C.
    Rocha, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 520 - 520
  • [29] Differentiating between non-functioning pituitary macroadenomas and sellar meningiomas using ADC
    Zhang, Jing
    Zhao, Zhiyong
    Dong, Li
    Han, Tao
    Zhang, Guojin
    Cao, Yuntai
    Zhou, Junlin
    ENDOCRINE CONNECTIONS, 2020, 9 (12): : 1233 - 1239
  • [30] Regrowth of non-functioning pituitary macroadenomas undergoing surgery in a single Australian centre
    Watts, Anna
    McNeill, Peter
    Inder, Warrick
    Wang, Yi Yuen
    Caputo, Carmela
    CLINICAL ENDOCRINOLOGY, 2016, 84 : 42 - 42